Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.059 | 0.7 |